A human pluripotent stem cell platform for assessing developmental neural toxicity screening

Stem Cell Research and Therapy

Volumn 4, Issue SUPPL.1, 2013, Pages

  Hou, Zhonggang ^a   Zhang, Jue ^a   Schwartz, Michael P ^b   Stewart, Ron ^a   Page, C David ^c   Murphy, William L ^b,d   Thomson, James A ^a,d,e  

^a MORGRIDGE INSTITUTE FOR RESEARCH   (United States)

^b University of Wisconsin Madison   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

developmental neural toxicity; human pluripotent stem cells; machine learning; Microphysiological Systems initiative; three dimensional hydrogel culture

Indexed keywords

BIOINFORMATICS; CELL CULTURE; CELL INTERACTION; CYTOLOGY; HUMAN; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; MACHINE LEARNING; NATIONAL HEALTH ORGANIZATION; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; NONHUMAN; PLURIPOTENT STEM CELL; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; TISSUE ENGINEERING; TOXICITY TESTING; ANIMAL; CHEMISTRY; DRUG EFFECT; EQUIPMENT; GENE EXPRESSION PROFILING; METHODOLOGY; MICROFLUIDIC ANALYSIS; MICROGLIA; NERVOUS SYSTEM DEVELOPMENT; PERICYTE;

TOXIN;

ANIMALS; GENE EXPRESSION PROFILING; HUMANS; HYDROGELS; MICROFLUIDIC ANALYTICAL TECHNIQUES; MICROGLIA; NEUROGENESIS; PERICYTES; PLURIPOTENT STEM CELLS; TOXINS, BIOLOGICAL;

EID: 84891351756     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt373     Document Type: Review

References (33)

1. Hazard identification and predictability of children's health risk from animal data. Morford LL, Henck JW, Breslin WJ, DeSesso JM, Environ Health Perspect 2004 112 266 271 14754582 (Pubitemid 38195836)
2. Toxicology. Transforming environmental health protection. Collins FS, Gray GM, Bucher JR, Science 2008 319 906 907 10.1126/science.1154619 18276874 (Pubitemid 351263750)
3. Toxicology for the twenty-first century. Hartung T, Nature 2009 460 208 212 10.1038/460208a 19587762
4. Chemical regulators have overreached. Hartung T, Rovida C, Nature 2009 460 1080 1081 10.1038/4601080a 19713914
5. US Environmental Protection Agency, Chemical Hazard Data Availability Study Washington, DC: EPA Office of Pollution Prevention and Toxics 1998
6. Toxicity testing in the 21st century: implications for human health risk assessment. Krewski D, Andersen ME, Mantus E, Zeise L, Risk Anal 2009 29 474 479 10.1111/j.1539-6924.2008.01150.x 19144067
7. The ToxCast program for prioritizing toxicity testing of environmental chemicals. Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ, Toxicol Sci 2007 95 5 12 16963515 (Pubitemid 44942773)
8. Committee on Toxicity Testing and Assessment of Environmental Agents NRC, Toxicity Testing for Assessment of Environmental Agents: Interim Report Washington, DC: The National Academies Press 2006
9. Susceptibility of certain inbred strains of hamsters to teratogenic effects of thalidomide. Homburger F, Chaube S, Eppenberger M, Bogdonoff PD, Nixon CW, Toxicol Appl Pharmacol 1965 7 686 693 10.1016/0041-008X(65)90126-2 5866808
10. Workshop to identify critical windows of exposure for children's health: neurobehavioral work group summary. Adams J, Barone S, LaMantia A, Philen R, Rice DC, Spear L, Susser E, Environ Health Perspect 2000 108 Suppl 3 535 544 10852852 (Pubitemid 30466180)
11. Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Moors M, Rockel TD, Abel J, Cline JE, Gassmann K, Schreiber T, Schuwald J, Weinmann N, Fritsche E, Environ Health Perspect 2009 117 1131 1138 10.1289/ehp.0800207 19654924
12. Embryonic stem cell lines derived from human blastocysts. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM, Science 1998 282 1145 1147 9804556 (Pubitemid 28516247)
13. Induced pluripotent stem cell lines derived from human somatic cells. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA, Science 2007 318 1917 1920 10.1126/science.1151526 18029452
14. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
15. In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints. Bal-Price AK, Hogberg HT, Buzanska L, Lenas P, van Vliet E, Hartung T, Neurotoxicology 2010 31 545 554 10.1016/j.neuro.2009.11.006 19969020
16. Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. Breier JM, Gassmann K, Kayser R, Stegeman H, De Groot D, Fritsche E, Shafer TJ, Neurotoxicol Teratol 2010 32 4 15 10.1016/j.ntt.2009.06.005 19559083
17. Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Colleoni S, Galli C, Gaspar JA, Meganathan K, Jagtap S, Hescheler J, Sachinidis A, Lazzari G, Toxicol Sci 2011 124 370 377 10.1093/toxsci/kfr245 21934132
18. Neural differentiation from human embryonic stem cells as a tool to study early brain development and the neuroteratogenic effects of ethanol. Talens-Visconti R, Sanchez-Vera I, Kostic J, Perez-Arago MA, Erceg S, Stojkovic M, Guerri C, Stem Cells Dev 2011 20 327 339 10.1089/scd.2010.0037 20491543
19. Neural differentiation of rhesus embryonic stem cells. Thomson JA, Marshall VS, Trojanowski JQ, APMIS 1998 106 149 156 discussion 156-157 10.1111/j.1699-0463.1998.tb01330.x 9524573
20. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Eiraku M, Watanabe K, Matsuo-Takasaki M, Kawada M, Yonemura S, Matsumura M, Wataya T, Nishiyama A, Muguruma K, Sasai Y, Cell Stem Cell 2008 3 519 532 10.1016/j.stem.2008.09.002 18983967
21. Moving from static to dynamic complexity in hydrogel design. Burdick JA, Murphy WL, Nat Commun 2012 3 1269 23232399
22. An adaptable hydrogel array format for 3-dimensional cell culture and analysis. Jongpaiboonkit L, King WJ, Lyons GE, Paguirigan AL, Warrick JW, Beebe DJ, Murphy WL, Biomaterials 2008 29 3346 3356 10.1016/j.biomaterials.2008.04.040 18486205
23. Screening for 3D environments that support human mesenchymal stem cell viability using hydrogel arrays. Jongpaiboonkit L, King WJ, Murphy WL, Tissue Eng Part A 2009 15 343 353 10.1089/ten.tea.2008.0096 18759676
24. A versatile synthetic extracellular matrix mimic via thiol-norbornene photopolymerization. Fairbanks BD, Schwartz MP, Halevi AE, Nuttelman CR, Bowman CN, Anseth KS, Adv Mater 2009 21 5005 5010 10.1002/adma.200901808
25. Human embryonic stem cell-derived CD34§ssup§+ §esup§cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Vodyanik MA, Bork JA, Thomson JA, Slukvin II, Blood 2005 105 617 626 10.1182/blood-2004-04-1649 15374881 (Pubitemid 40070744)
26. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Kaufman DS, Lewis RL, Hanson ET, Auerbach R, Plendl J, Thomson JA, Blood 2004 103 1325 1332 14563647 (Pubitemid 38168644)
27. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA, Nat Biotechnol 2001 19 1129 1133 10.1038/nbt1201-1129 11731781 (Pubitemid 33115698)
28. Differentiation of human oligodendrocytes from pluripotent stem cells. Hu BY, Du ZW, Zhang SC, Nat Protoc 2009 4 1614 1622 10.1038/nprot.2009.186 19834476
29. Specification of transplantable astroglial subtypes from human pluripotent stem cells. Krencik R, Weick JP, Liu Y, Zhang ZJ, Zhang SC, Nat Biotechnol 2011 29 528 534 10.1038/nbt.1877 21602806
30. Valproic acid teratogenicity: a toxicogenomics approach. Kultima K, Nystrom AM, Scholz B, Gustafson AL, Dencker L, Stigson M, Environ Health Perspect 2004 112 1225 1235 10.1289/ehp.7034 15345369 (Pubitemid 39199563)
31. Arsenic and cadmium-induced toxicogenomic response in mouse embryos undergoing neurulation. Robinson JF, Yu X, Moreira EG, Hong S, Faustman EM, Toxicol Appl Pharmacol 2011 250 117 129 10.1016/j.taap.2010.09.018 20883709
32. Analysis of altered gene expression specific to embryotoxic chemical treatment during embryonic stem cell differentiation into myocardiac and neural cells. Suzuki N, Ando S, Sumida K, Horie N, Saito K, J Toxicol Sci 2011 36 569 585 10.2131/jts.36.569 22008533
33. Transcriptomic concentration-response evaluation of valproic acid, cyproconazole and hexaconazole in the neural embryonic stem cell test (ESTn). Theunissen PT, Robinson JF, Pennings JL, de Jong E, Claessen SM, Kleinjans JC, Piersma AH, Toxicol Sci 2012 125 430 438 10.1093/toxsci/kfr293 22045034